The popularity of Novo Nordisk's weight-loss drug Wegovy has made the Danish company the most valuable in Europe; Korean pharmas are now seeking a share of the lifestyle drugs market.
As the world grapples with the obesity epidemic, pharmaceutical companies are increasingly tapping into the fast-burgeoning market for weight-loss drugs.
Korea JoongAng Daily Sitemap